Article
Kinetic modeling of ImmunoPET enables in vivo quantification of EGFRvIII expression in glioblastoma
2026-04-20
Abstract excerpt
<title>Abstract</title> <p>Glioblastoma (GBM) remains the most lethal primary brain tumour in adults. Targeted strategies against epidermal growth factor receptor variant III (EGFRvIII), a tumour-specific mutation expressed in GBM, are advancing clinically; however, their success depends on accurate, non-invasive assessment of EGFRvIII-expression for patient selection. Here, we develop and validate an immuno-Posi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 338bf7b5-cf7a-5377-b4ea-6a9016db99e2
- DOI
- 10.21203/rs.3.rs-9177895/v1
